Color co-founder and CEO Othman Laraki explains his company’s abrupt shift from an exclusive focus on genetic testing to COVID testing in March of 2020. As the company realized that their cutting-edge lab was well positioned to help address the country’s critically under-resourced testing capabilities, they decided to apply their technology to COVID testing, and further build the company’s focus on disseminating healthcare solutions to large populations.
Related
Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.
Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
